Introduction
Candida albicans is a commensal organism in healthy individuals, but often causes life-threatening bloodstream infections (BSIs) in hospitalized patients [1] . Recent investigations have shown that C. albicans BSIs are frequently associated with biofi lm formation on vascular catheters [2, 3] . C. albicans is the third leading cause of intravascular catheter-related BSIs, with the second highest catheter colonization-to-infection rate [3] . Biofi lm-correlated with in vivo denture stomatitis severity [6] . Therefore, it is possible that Saps play a role in biofi lmassociated BSIs caused by C. albicans , and that different SAP genes may be differentially expressed in BSI isolates under biofi lm conditions, which may contribute to biofi lm-associated BSIs. However, to date, there is a lack of substantial research on quantitative expression of SAP genes in C. albicans biofi lms formed by BSI isolates.
Of the 10 SAP genes, SAP4 -6 are predominantly expressed in hyphae [1] and hyphae are the predominant forms in biofi lm growth in the in vivo model [7] . On the other hand, SAP9 -and SAP10 -encoded proteins maintain cell surface integrity by processing cell wall proteins, which mediate biofi lm formation [8, 9] . C. albicans forms biofi lms on abiotic and biotic surfaces such as the oral and vaginal mucosas [4, 10] . Naglik has shown that SAP5 and SAP9 are the major SAPs expressed in vivo in mucosal biofi lms [4] . In this study, we examined the expression of these two SAP genes, SAP5 and SAP9 , in in vitro biofi lms formed on abiotic surfaces by C. albicans BSI isolates. Expression of the two SAP genes was determined during the intermediate (24 h) and mature (48 h) phases of biofi lm development by real-time polymerase chain reaction (PCR), and the results were compared with those for clinical isolates from other body sites.
Materials and methods

C. albicans isolates
A total of 63 C. albicans isolates were analyzed, which included 35 BSI isolates and 28 clinical isolates from other body sites. The latter were obtained from cultures of the oral cavity ( n ϭ 9), sputum ( n ϭ 10), and vaginal discharge ( n ϭ 9) of patients who were not wearing dentures or other artifi cial prostheses. All 35 BSI isolates were collected from patients with candidemia in whom central venous catheters were in place. All isolates were obtained from patient as part of the routine diagnostic procedures that were conducted at Chonnam National University Hospital from 2006 -2010. Duplicate isolates from the same patient were excluded. C. albicans was identifi ed by colony morphology on CHROMagar Candida (BBL, Becton Dickinson, Sparks, MD, USA), along with a commercially available biochemical identifi cation system, i.e., the API 20C system (bioM é rieux, Marcy L ' Etoile, France) or the Vitek 2 system (Vitek 2 ID-YST, bioM é rieux).
Biofi lm formation
For biofi lm formation, we used a denture strip model with 12-well tissue culture plates that has been used with Candida species [11, 12] . Briefl y, a standard inoculum of 10 7 cells/ml from an overnight culture of the C. albicans strain was applied to the surface of a 1.5-cm 2 denture strip (Nunc 174969 Thermanox Coverslips; diameter, 15 mm; Naperville, IL, USA), which was then placed in a well of a 12-well tissue culture plate with 4 ml of phosphatebuffered saline (PBS). The cells were then allowed to adhere for 90 min at 37 ° C, with non-adherent cells subsequently removed from the strips by gentle washing with 5 ml of PBS. The strips were then submerged in 4 ml of yeast nitrogen base medium supplemented with 50 mM dextrose (YNBD) and incubated for 24 and 48 h at 37 ° C on a rocker. Planktonic cultures were grown in the same way as the biofi lms, except that glass tubes were used, and denture strips were not added [5, 13] . For each biofi lm, biofi lm biomass was measured using a colorimetric XTT [2,3-bis (2-methoxy-4nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide] assay, as reported previously [12] .
Real-time PCR analysis of C. albicans SAP gene expression
Total RNA was isolated from biofi lms (24 and 48 h) and planktonic cells [11] and was analyzed by real-time reverse transcription (RT)-PCR [4] . SAP5 and SAP9 expression was quantifi ed by real-time RT-PCR using a ROTOR Gene 3000 system (Corbett Research, Sydney, Australia). Primers and fl uorescent probes were used as reported previously [4] , and the calibration and efficiency of the primer/probe sets was assessed in titration experiments using serial dilutions of C. albicans SC5314 genomic DNA (500 ng to 5 pg). The expression of each gene was calculated with reference to the respective standard curve using Corbett Research software and normalized as the ratio of the target ( SAP5 and SAP9 ) and housekeeping ( ACT1 ) gene expression levels from separate reactions. Each reaction was performed in triplicate. Real-time PCR data were normalized with the geometric mean of ACT1 [10] , and data are presented as mRNA transcript (arbitrary units [AU]) relative to ACT1 (10,000 AU) [4] . For all biofi lms, relative gene expression levels were reported as the fold change determined as the mean normalized expression relative to that of corresponding planktonic cells (set as 1.0). The levels of SAP or ACT1 expression between biofi lms and planktonic cells were compared by Wilcoxon matched-pairs signed rank test using the SPSS Win 18.0 program. The levels of SAP expression or biofi lm biomass formation between BSI isolates and isolates from other sites were compared by using Mann-Whitney U test. Correlations between the SAP gene expression and biofi lm biomass formation were examined by using Spearman ' s test. Differences corresponding planktonic cells, for 35 BSI isolates and 28 isolates from other sites. Mean SAP5 gene expression levels in the 35 BSI isolates were 3.59-fold and 3.86-fold higher in the 24-h and 48-h biofi lms, respectively, similar values to those for the 28 isolates from other body sites (2.71-fold and 2.80-fold higher in the 24-h and 48-h biofi lms, respectively). Mean SAP9 expression levels in all BSI isolates were 2.89-fold and 3.29-fold higher in the 24-h and 48-h biofi lms, respectively, and signifi cantly higher than those in all isolates from other sites (1.27-fold and 1.32-fold at 24 and 48 h, respectively; P Ͻ 0.001 for both 24-h and 48-h biofi lms). The majority of clinical isolates of C. albicans showed higher levels of SAP5 expression ( Ͼ 1.0-fold) in 24-h biofi lms (89% of BSI isolates and 100% isolates from other sites) and in 48-h biofi lms (97% of BSI isolates and 82% isolates from other sites). Higher SAP9 gene expression ( Ͼ 1.0-fold) under 24-h and 48-h biofi lm conditions was observed in 97% (34/35) and 100% (35/35) of BSI isolates, respectively, compared with 75% (21/28) and 68% (19/28) of isolates from other sites, respectively ( P Ͻ 0.01 for both 24-h and 48-h biofi lms).
The levels of biofi lm biomass formation determined by XTT assay (values expressed in OD units at 492 nm) were highly variable among BSI isolates (0.087 ∼ 0.364), or those from other sites (0.066 ∼ 0.352). The mean OD (standard deviation) did not differ signifi cantly between BSI isolates and those from other sites at 24 h (0.253 Ϯ 0.062 versus 0.229 Ϯ 0.079, P Ͼ 0.05) or 48 h (0.224 Ϯ 0.057 vs. 0.202 Ϯ 0.056, P Ͼ 0.05). In addition, no signifi cant correlations were found between levels of SAP5 or SAP9 between groups were considered signifi cant when P was Ͻ 0.05. Figure 1 presents the expression of the SAP5 and SAP9 genes, relative to that of ACT1 (10,000 AU), in 63 clinical isolates of C. albicans under planktonic and biofi lm conditions. The expression of ACT1 did not differ signifi cantly throughout the experiment between biofi lms and planktonic cells. For all 63 isolates, median (range) ACT1 copy number per 100 ng RNA was 758 (177 ∼ 2677) in 24-h biofi lms, and 1178 (304 ∼ 2918) in 48-h biofi lms, both of which did not show signifi cant differences, compared with corresponding planktonic cells [789 (323 ∼ 2021) and 1154 (213 ∼ 2328) at 24 h and 48 h, respectively] (both, P Ͼ 0.05). For all 63 isolates, mean (standard deviation) SAP5 expression levels were 3452 Ϯ 2861 AU in 24-h biofi lms, and 3862 Ϯ 3567 AU in 48-h biofi lms, both of which were higher than those in corresponding planktonic cells [1563 Ϯ 1923 and 2052 Ϯ 2816 AU at 24 and 48 h, respectively] (both, P Ͻ 0.0001). In addition, mean SAP9 expression in 24-and 48-h biofi lms were 11,357 Ϯ 5237 and 9761 Ϯ 7006 AU, respectively, which were also higher than in those in corresponding planktonic cells [6539 Ϯ 3127 and 5022 Ϯ 3016 AU at 24 h and 48 h, respectively] (both, P Ͻ 0.0001). No correlation was found between SAP5 and SAP9 expression levels in 63 clinical isolates of C. albicans under biofi lm conditions. Figure 2 shows the relative gene expression of biofi lms, presented as the fold change relative to the 
Results
Discussion
C. albicans infections are often associated with biofi lm formation [2, 3] . Various model systems have been developed to study C. albicans biofi lm biology on abiotic and mucosal surfaces [4, 10] . In this study, we examined the expression of two SAP genes in in vitro C. albicans biofi lms grown on an abiotic surface using the denturestrip biofi lm model, which may refl ect in vivo biofi lm formation on indwelling medical devices, such as intravascular catheters. All BSI isolates used in this study were from patients in whom central venous catheters were in place. Our results show that expression levels of both SAP5 and SAP9 were upregulated in C. albicans biofi lms formed by BSI isolates, and that SAP9 was more likely to be upregulated in C. albicans biofi lms formed by BSI isolates than those formed by isolates from other sites. We believe this to be the fi rst study to compare the quantitative expression of SAP5 and SAP9 genes on in vitro C. albicans biofi lms according to their clinical sources .
We used real-time quantitative PCR methods established by Naglik et al . [4] to measure SAP gene expression in C. albicans planktonic cells and biofi lms. Using these methods, Naglik et al . demonstrated that SAP5 and SAP9 were the most highly expressed SAP genes in mucosa samples from patients with oral or vaginal candidiasis [4] . Our results show that the expression levels of both SAP5 and SAP9 genes in in vitro biofi lms formed by most clinical isolates of C. albican s were signifi cantly higher than those in planktonic cells, supporting the previous fi ndings that C. albicans biofi lms on abiotic surfaces secrete more Saps than planktonic cells [5, 6] . A recent study to investigate whether SAP genes are highly expressed in biofi lms associated with abiotic surfaces, showed that all SAP genes (except for SAP3 ) were upregulated in the various biofi lm model systems formed by a reference strain, C. albicans SC5314 [10]. Our results using 63 clinical isolates of C. albicans disclosed the strain-dependent differences in the expression level of SAP5 and SAP9 genes under biofi lm conditions.
Of the 10 SAP s, expression of SAP4 -6 has been demonstrated in all mucosal and systemic infections by C. albicans examined [1, 4, 14] . In addition, C. albicans expresses the SAP4 -6 ubiquitously in all Candida carriers and patients with oral and vaginal candidiasis, regardless of the infection model, suggesting that this proteinase subfamily plays an important role in C. albicans colonization and infection [1] . Our data show that most clinical isolates of C. albicans from blood, the oral cavity, sputum, and vaginal discharge expressed SAP5 in in vitro biofi lms, and no differences were found in mean biofi lm SAP5 expression levels between the BSI isolates and those from other sites. These data suggest that SAP5 may also play an important role in biofi lm-associated colonization and infection caused by C. albicans , regardless of type of infection (mucosal or bloodstream).
In contrast to other Saps, Sap9 and Sap10 are not secreted by the fungus, but are glycosylphosphatidylinositol (GPI)-anchored proteins that play a role in cell surface integrity [1, 15, 16] . Our study using 63 clinical isolates of C. albicans showed no correlation between SAP5 and SAP9 expression levels under biofi lm conditions. Schild et al . recently proposed that Sap9 and Sap10 infl uence distinct cell wall functions by proteolytic cleavage of covalently linked cell wall proteins [9] , which mediate biofi lm formation and promote adherence to host cells and invasion into epithelial cell layers [16] . Our results show that C. albicans BSI isolates have a higher ability to express SAP9 under biofi lm conditions than isolates from other clinical sites, suggesting that the SAP genes expressed or required by C. albicans to cause biofi lm-associated infections may vary depending on the type of infection (i.e., mucosal or systemic), and that SAP9 is more likely to play an important role in biofi lmassociated BSIs than other infections by C. albicans .
Although the SAP genes expressed by C. albicans under in vitro biofi lm conditions may not equate to the SAP genes expressed in vivo , these fi ndings suggests that a BSI may result from selecting C. albicans strains with higher expression of both SAP5 and SAP9 in association with biofi lm formation. No signifi cant correlations between levels of SAP5 or SAP9 expression and biofi lm biomass formation among clinical isolates suggest that expression of these two SAP genes may be not directly related to the level of biofi lm formation. The higher SAP9 expression of BSI isolates of C. albicans under biofi lm conditions, together with strain-specifi c differences of SAP gene expression, may refl ect the fact that strainspecifi c factors secreted from C. albicans within the biofi lm may be more important in causing biofi lm-associated BSIs than the presence of a biofi lm alone or the level of biofi lm formation [6] , although this hypothesis requires further investigation.
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